Talay Fahrettin, Kumbetli Senol, Altin Sedat
Department of Chest Diseases, Izzet Baysal Faculty of Medicine, Abant Izzet Baysal University, Bolu, Turkey.
Jpn J Infect Dis. 2008 Jan;61(1):25-30.
We aimed to evaluate the treatment outcome of pulmonary tuberculosis patients and factors affecting treatment outcomes. We analyzed the records of 586 pulmonary tuberculosis patients who were older than 15 years followed between January 1999 and December 2004. Of these patients, 76.1% were smear-positive for tuberculosis and 23.9% were smear-negative for tuberculosis. The treatment outcomes of all patients analyzed were as follows: treatment success 91.7%, defaulted treatment 5.1%, died 2.4%, failure 0.3%, and transferred out 0.5%. The treatment outcomes of smear-positive pulmonary tuberculosis patients were as follows: cured 77.1%, treatment completed 13.5%, defaulted treatment 5.4%, died 2.9%, failure 0.4%, and transferred out 0.7%. In multivariate regression analysis, risk factors for non-successful treatment outcome were determined to be re-treatment patients, patients older than 46 years of age, and the presence of rifampicin resistance. We conclude that application of Directly Observed Therapy may increase treatment success in all patients, especially patients who have risk factors for a low treatment success rate.
我们旨在评估肺结核患者的治疗结果以及影响治疗结果的因素。我们分析了1999年1月至2004年12月期间随访的586例年龄超过15岁的肺结核患者的记录。在这些患者中,76.1%的患者结核涂片阳性,23.9%的患者结核涂片阴性。所有分析患者的治疗结果如下:治疗成功91.7%,中断治疗5.1%,死亡2.4%,治疗失败0.3%,转出0.5%。结核涂片阳性肺结核患者的治疗结果如下:治愈77.1%,完成治疗13.5%,中断治疗5.4%,死亡2.9%,治疗失败0.4%,转出0.7%。在多因素回归分析中,确定治疗结果未成功的危险因素为复治患者、年龄超过46岁的患者以及存在利福平耐药。我们得出结论,直接观察治疗的应用可能会提高所有患者的治疗成功率,尤其是那些治疗成功率低的危险因素患者。